QQQM combines low fees and tax efficiency with strong tech exposure, but carries concentration risks for short-term investors ...

Definitive Health beats on Q2 revenue and EPS, but weak Life Sciences subscriptions and structural pressures remain. Read why ...

After last week’s drop, Cisco is now trading at 16x and 15x expected EPS for fiscal ’26 and fiscal ’27 with expected y-o-y EPS growth of 7% and 8%, respectively.

Despite raising FY 2025 revenue guidance, SoundHound AI remains unprofitable, with widening losses. Read why I am not ...